Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Castelnovo

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Neurology|June 17, 1999
High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2C Denier, A Ducros, K Vahedi, et al.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Neurology|June 17, 1999
High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2C Denier, A Ducros, K Vahedi, et al.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
Neurology|March 3, 2010
Neuromyelitis optica in France: a multicenter study of 125 patientsN Collongues, R Marignier, H Zéphir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2015
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre studyJ Kuhle, G Disanto, R Dobson, et al.
Pageof 6